Eisai Inc. · Woodcliff Lake, NJ United States
Company Description
View Eisai Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Eisai Inc. develops and markets pharmaceuticals to treat a variety of ills. As the US pharmaceutical production arm of Eisai Co. , its current product roster includes Alzheimer's treatment Aricept, Aciphex for acid reflux, anticoagulant Fragmin, and anti-convulsant Zonegran. It also maintains an extensive pipeline of potential drugs to address cancer, epilepsy, and severe infection. While Eisai Inc. is busy with drug manufacturing and marketing operations, its sister companies Eisai Research Institute and Eisai Medical Research conduct, well, research. All are kept under holding company Eisai Corporation of North America. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Eisai Inc. Financials
| Company Type | Subsidiary Headquarters |
| Fiscal Year-End | March |
| Employees | 900 |
Eisai Inc. Executives
9 executives listed for Eisai Inc.'s Woodcliff Lake, NJ location.
| Title | Name & Bio | Contact |
| Chairman and CEO | Hajime Shimizu | Network |
| President and COO | Lonnel Coats | Network |
| SVP Primary Care and Specialty Business Unit | Ann Miller | Network |
Competition
Competitive Landscape for Eisai Inc.
Demand for biotechnology research in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. Funding for biotech research is often provided by venture capital funds hoping to cash in on new products. The profitability of individual companies depends on the discovery and effective marketing of new products. Because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research. The industry is capital intensive: average annual revenue per worker is more than $350,000. Biotech firms face stiff competition from pharmaceutical and other companies seeking to be first with a new product or discovery. To read the full description, subscribe now.Top Eisai Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!